Synthesis, Evaluation and Proposed Binding Pose of Substituted Spiro-Oxindole Dihydroquinazolinones as IRAP Inhibitors.


Journal

ChemistryOpen
ISSN: 2191-1363
Titre abrégé: ChemistryOpen
Pays: Germany
ID NLM: 101594811

Informations de publication

Date de publication:
03 2020
Historique:
received: 22 11 2019
revised: 23 01 2020
entrez: 11 3 2020
pubmed: 11 3 2020
medline: 11 3 2020
Statut: epublish

Résumé

Insulin-regulated aminopeptidase (IRAP) is a new potential macromolecular target for drugs aimed for treatment of cognitive disorders. Inhibition of IRAP by angiotensin IV (Ang IV) improves the memory and learning in rats. The majority of the known IRAP inhibitors are peptidic in character and suffer from poor pharmacokinetic properties. Herein, we present a series of small non-peptide IRAP inhibitors derived from a spiro-oxindole dihydroquinazolinone screening hit (pIC

Identifiants

pubmed: 32154052
doi: 10.1002/open.201900344
pii: OPEN201900344
pmc: PMC7050655
doi:

Substances chimiques

Oxindoles 0
Protease Inhibitors 0
Quinazolinones 0
Receptors, Angiotensin 0
Cystinyl Aminopeptidase EC 3.4.11.3
leucyl-cystinyl aminopeptidase EC 3.4.11.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

325-337

Informations de copyright

© 2020 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.

Références

ACS Chem Neurosci. 2016 Oct 19;7(10):1383-1392
pubmed: 27501164
Eur J Biochem. 2000 Jan;267(1):46-52
pubmed: 10601849
Bioorg Med Chem Lett. 2013 Sep 1;23(17):4832-6
pubmed: 23916253
J Biol Chem. 1997 Sep 12;272(37):23323-7
pubmed: 9287343
ACS Omega. 2018 Apr 30;3(4):4509-4521
pubmed: 30023895
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Nat Rev Mol Cell Biol. 2002 Apr;3(4):267-77
pubmed: 11994746
Assay Drug Dev Technol. 2016 Apr;14(3):180-93
pubmed: 27078680
Curr Pharm Des. 2009;15(31):3656-70
pubmed: 19925418
J Med Chem. 2010 Nov 25;53(22):8059-71
pubmed: 21047126
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19890-5
pubmed: 24248368
J Med Chem. 2015 Feb 12;58(3):1524-43
pubmed: 25635706
J Am Chem Soc. 2008 Nov 26;130(47):15786-7
pubmed: 18975905
J Med Chem. 2009 Sep 24;52(18):5612-8
pubmed: 19757839
Curr Opin Chem Biol. 2014 Dec;23:1-7
pubmed: 25173825
Am J Physiol. 1997 Apr;272(4 Pt 1):E600-6
pubmed: 9142880
Eur J Pharmacol. 2013 Feb 28;702(1-3):93-102
pubmed: 23376157
Neuroscience. 1988 Dec;27(3):777-83
pubmed: 3252173
J Mol Graph Model. 2008 Sep;27(2):170-7
pubmed: 18524655
Brain Res. 1992 Jun 26;583(1-2):340-3
pubmed: 1504842
Biochem Pharmacol. 2004 Sep 1;68(5):885-92
pubmed: 15294451
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Brain Res. 1995 Jun 5;682(1-2):13-21
pubmed: 7552303
J Pept Sci. 2006 Nov;12(11):705-13
pubmed: 16967438
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E1092-102
pubmed: 17684103
Eur J Pharmacol. 2000 Sep 29;405(1-3):63-72
pubmed: 11033315
Mol Pharmacol. 2016 Apr;89(4):413-24
pubmed: 26769413
Protein Sci. 2015 Feb;24(2):190-9
pubmed: 25408552
J Med Chem. 2011 Jun 9;54(11):3779-92
pubmed: 21476495
J Med Chem. 2017 Apr 13;60(7):2963-2972
pubmed: 28328206
FASEB J. 2008 Dec;22(12):4209-17
pubmed: 18716029
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20377-81
pubmed: 19918052
Drug Discov Today. 2001 Apr 1;6(8):406-416
pubmed: 11301285
PLoS One. 2012;7(10):e46764
pubmed: 23071631
ChemistryOpen. 2020 Mar 02;9(3):325-337
pubmed: 32154052
J Pept Sci. 2007 Jul;13(7):434-44
pubmed: 17559064
Bioorg Med Chem. 2008 Jul 15;16(14):6924-35
pubmed: 18556208
J Med Chem. 2014 Feb 27;57(4):1368-77
pubmed: 24471437
ChemistryOpen. 2014 Dec;3(6):256-63
pubmed: 25558444
Eur J Biochem. 2001 Jun;268(11):3259-66
pubmed: 11389728
Brain Res. 1995 Dec 1;701(1-2):301-6
pubmed: 8925296
J Mol Graph Model. 1998 Aug-Dec;16(4-6):213-25, 261
pubmed: 10522241
J Neurochem. 2020 May;153(4):485-494
pubmed: 31556456

Auteurs

Karin Engen (K)

Department of Medicinal Chemistry Uppsala University SE-751 23 Uppsala SWEDEN.

Sudarsana Reddy Vanga (SR)

Department of Cell and Molecular Biology Uppsala University SE-751 23 Uppsala SWEDEN.

Thomas Lundbäck (T)

Chemical Biology Consortium Sweden, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics Karolinska Institutet SE-171 65 Solna SWEDEN.
Mechanistic Biology & Profiling, Discovery Sciences, R&D AstraZeneca SE-431 83 Göteborg SWEDEN.

Faith Agalo (F)

Department of Medicinal Chemistry Uppsala University SE-751 23 Uppsala SWEDEN.

Vivek Konda (V)

Department of Medicinal Chemistry Uppsala University SE-751 23 Uppsala SWEDEN.

Annika Jenmalm Jensen (AJ)

Chemical Biology Consortium Sweden, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics Karolinska Institutet SE-171 65 Solna SWEDEN.

Johan Åqvist (J)

Department of Cell and Molecular Biology Uppsala University SE-751 23 Uppsala SWEDEN.

Hugo Gutiérrez-de-Terán (H)

Science for Life Laboratory, Department of Cell and Molecular Biology Uppsala University SE-751 23 Uppsala SWEDEN.

Mathias Hallberg (M)

The Beijer Laboratory, Department of Pharmaceutical Biosciences Uppsala University SE-751 23 Uppsala SWEDEN.

Mats Larhed (M)

Science for Life Laboratory, Department of Medicinal Chemistry Uppsala University SE-751 23 Uppsala SWEDEN.

Ulrika Rosenström (U)

Department of Medicinal Chemistry Uppsala University SE-751 23 Uppsala SWEDEN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH